Valuation: MiMedx Group, Inc.

Market Cap 646M 574M 532M 484M 913M 61.28B 928M 6.39B 2.51B 31.98B 2.42B 2.37B 102B P/E 2026 *
-24.6x
P/E 2027 * 73.8x
Enterprise Value 646M 574M 532M 484M 913M 61.28B 928M 6.39B 2.51B 31.98B 2.42B 2.37B 102B EV / Sales 2026 *
2.42x
EV / Sales 2027 * 2x
Free-Float
95.59%
Yield 2026 *
-
Yield 2027 * -
1 day-5.34%
1 week-5.14%
Current month-4.94%
1 month-5.54%
3 months+3.02%
6 months+29.72%
Current year-34.56%
1 week 4.4
Extreme 4.4
4.88
1 month 4.4
Extreme 4.4
4.99
Current year 3.02
Extreme 3.025
6.79
1 year 3.02
Extreme 3.025
7.97
3 years 3.02
Extreme 3.025
10.14
5 years 2.43
Extreme 2.43
10.14
10 years 0.95
Extreme 0.95
18.25
Manager TitleAgeSince
Chief Executive Officer 63 2023-01-26
Director of Finance/CFO 60 2023-07-04
Chief Tech/Sci/R&D Officer - 2021-05-31
Director TitleAgeSince
Director/Board Member 73 2019-06-18
Chairman 73 2019-06-18
Director/Board Member 63 2019-06-18
Date Insider Type Main position Quantity % Market Cap. Importance
7/2/26 Tax

Chief Financial Officer

-12,749 0.0086%
3/13/26 Tax

Executive/Senior Manager

6,762 0.0046%
3/13/26 Tax

Chief Administrative Officer

20,245 0.0136%
Change 5-day change 1-year change 3-year change Capi.($)
-5.34%-5.14%-33.78%-33.48% 646M
-6.60%-8.56%+49.38%+63.51% 65B
+0.03%+5.56%+9.10%+69.05% 51.2B
-4.09%-0.11%+2.22%+53.15% 51.19B
-1.53%+2.70%+30.48%+34.12% 43.93B
-1.34%+4.12%+16.64%+115.13% 41.96B
-5.97%-6.22%+228.95%+454.22% 38.14B
+6.53%+8.02%+16.40%+53.41% 33.24B
-0.90%-10.49%+37.09%-3.70% 25.2B
-1.07%+2.33%+19.43%+9.98% 22.5B
Average -2.03%-0.83%+37.59%+81.54% 37.3B
Weighted average by Cap. -2.20%-0.51%+44.11%+96.31%

Financials

2026 *2027 *
Net sales 267M 237M 220M 200M 378M 25.34B 384M 2.64B 1.04B 13.22B 1B 981M 42.16B 323M 288M 266M 242M 458M 30.7B 465M 3.2B 1.26B 16.02B 1.21B 1.19B 51.07B
Net income -26.85M -23.87M -22.12M -20.13M -37.98M -2.55B -38.59M -266M -104M -1.33B -101M -98.62M -4.24B 9.13M 8.12M 7.52M 6.85M 12.92M 867M 13.13M 90.45M 35.46M 452M 34.28M 33.55M 1.44B
Net Debt - -
Projected Income Statement - Annual - MiMedx Group, Inc.
Logo MiMedx Group, Inc.
MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.
Employees
808
Date Price Change Volume
26-10-16 US$4.430 -5.34% 2,728,257
26-10-15 US$4.680 -0.43% 1,331,062
26-10-14 US$4.700 +0.21% 1,635,491
26-10-13 US$4.690 -2.90% 972,932
26-10-12 US$4.830 +3.43% 625,570
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
MarketScreener Ratings - MiMedx Group, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
4.430USD
Average target price
7.400USD
Spread / Average Target
+67.04%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - MiMedx Group, Inc.
  1. Stock Market
  2. Stocks
  3. MDXG Stock